Type of Project: Funded project Model project Scientific Work Study
INN³plus. Improvements through a combination of medical-occupational rehabilitation and inclusive and motivational psychotherapy

The project tests an intensified, individual inclusive psychotherapy in addition to the combined medical and occupational rehabilitation treatment of INN3. Members of the target group are not able to benefit from regular occupational rehabilitation programmes. They have impaired psychical and somatic functional abilities connected with conflictual or straining context factors. These can occur in combination with disappointing or conflictual social or work related experiences. In the individual therapy sessions, these hitherto untreated insured persons will work on their varying conflicts and work related anxieties and adjustment disorders, while they develop strategies for life choice changes and social inclusion. The project’s goals are: - Preparation of the insured people for the reintegration into the labour market - Improved rehabilitation outcome prediction for participants as opposed to assessments in standard consultations - An increase of the labour market reintegration of 20 per cent of participants compared to non-participants that have only received a conventional occupational rehabilitation The number of participants is approximately 250 persons during the intervention period of 42 months. The project is carried out at the BFW Bad Pyrmont, part of INN-tegrativ gGmbH, in cooperation with the Therapy Centre Friedrichshöhe Bad Pyrmont. The project’s aims and outcomes will be evaluated. The reintegration rate of participants and non-participants and their contribution periods will be compared. A survey of socio-demographic aspects, health conditions, personality traits, work motivation, and context factors is also conducted. In a qualitative setting 50 participants and non-participants are interviewed about their experiences of the program and focus groups with the specialised staff are being conducted. The project is led by Dr Axel Kobelt-Pönicke.